Global Hirudin Market Growth 2023-2029

This report studies the Hirudin market. Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin. Hirudin (hirudin) is a Leech (Leech) and salivary glands have been extracted from a variety of active ingredients in the activity of the most significant and most studied ingredients, which is 65-66 amino acids from the small molecules of protein (peptide) . Hirudin have strong inhibitory effect on thrombin is the strongest so far found in the natural specific inhibitor of thrombin. Animal experiments and clinical studies have shown that hirudin can be effective anticoagulant, antithrombotic, and prevent thrombin-catalyzed activation of coagulation factors and platelet reactions and blood stasis phenomenon further. In addition, it also inhibited thrombin-induced fibroblast proliferation, and thrombin stimulation of endothelial cells. Compared with heparin, which not only use less, do not cause bleeding, is not dependent on endogenous cofactor; and heparin have caused the risk of bleeding, disseminated intravascular coagulation in the pathogenesis of antithrombin III are reduced This will limit the efficacy of heparin, using leeches will have good results.

LPI (LP Information)' newest research report, the “Hirudin Industry Forecast” looks at past sales and reviews total world Hirudin sales in 2022, providing a comprehensive analysis by region and market sector of projected Hirudin sales for 2023 through 2029. With Hirudin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hirudin industry.

This Insight Report provides a comprehensive analysis of the global Hirudin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hirudin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Hirudin market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hirudin and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hirudin.

The global Hirudin market size is projected to grow from US$ 3888.5 million in 2022 to US$ 4853 million in 2029; it is expected to grow at a CAGR of 4853 from 2023 to 2029.

Global Hirudin key players include Pfizer, Teva Pharmaceutical, The Medicines Company, SALUBRIS, DUOPUTAI, etc. Global top five manufacturers hold a share about 20%. North America is the largest market, with a share about 30%, followed by Europe, with a share about 20 percent. In terms of product, Natural Hirudin is the largest segment, with a share about 55%. And in terms of application, the largest application is Thrombosis Disease, followed by Tumor Disease, etc.

This report presents a comprehensive overview, market shares, and growth opportunities of Hirudin market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:
Segmentation by type
    Natural Hirudin
    Recombinant Hirudin

Segmentation by application
    Thrombosis Disease
    Tumor Disease
    Others

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
    The Medicines Company
    Keyken
    Minapharm
    Abbott
    SALUBRIS
    Pfizer, Inc
    Teva Pharmaceutical Industries Ltd
    DUOPUTAI
    Pentapharm

Key Questions Addressed in this Report
What is the 10-year outlook for the global Hirudin market?
What factors are driving Hirudin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Hirudin market opportunities vary by end market size?
How does Hirudin break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

List of Tables
    Table 1. Hirudin Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
    Table 2. Hirudin Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
    Table 3. Major Players of Natural Hirudin
    Table 4. Major Players of Recombinant Hirudin
    Table 5. Global Hirudin Sales by Type (2018-2023) & (K MT)
    Table 6. Global Hirudin Sales Market Share by Type (2018-2023)
    Table 7. Global Hirudin Revenue by Type (2018-2023) & ($ million)
    Table 8. Global Hirudin Revenue Market Share by Type (2018-2023)
    Table 9. Global Hirudin Sale Price by Type (2018-2023) & (USD/MT)
    Table 10. Global Hirudin Sales by Application (2018-2023) & (K MT)
    Table 11. Global Hirudin Sales Market Share by Application (2018-2023)
    Table 12. Global Hirudin Revenue by Application (2018-2023)
    Table 13. Global Hirudin Revenue Market Share by Application (2018-2023)
    Table 14. Global Hirudin Sale Price by Application (2018-2023) & (USD/MT)
    Table 15. Global Hirudin Sales by Company (2018-2023) & (K MT)
    Table 16. Global Hirudin Sales Market Share by Company (2018-2023)
    Table 17. Global Hirudin Revenue by Company (2018-2023) ($ Millions)
    Table 18. Global Hirudin Revenue Market Share by Company (2018-2023)
    Table 19. Global Hirudin Sale Price by Company (2018-2023) & (USD/MT)
    Table 20. Key Manufacturers Hirudin Producing Area Distribution and Sales Area
    Table 21. Players Hirudin Products Offered
    Table 22. Hirudin Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
    Table 23. New Products and Potential Entrants
    Table 24. Mergers & Acquisitions, Expansion
    Table 25. Global Hirudin Sales by Geographic Region (2018-2023) & (K MT)
    Table 26. Global Hirudin Sales Market Share Geographic Region (2018-2023)
    Table 27. Global Hirudin Revenue by Geographic Region (2018-2023) & ($ millions)
    Table 28. Global Hirudin Revenue Market Share by Geographic Region (2018-2023)
    Table 29. Global Hirudin Sales by Country/Region (2018-2023) & (K MT)
    Table 30. Global Hirudin Sales Market Share by Country/Region (2018-2023)
    Table 31. Global Hirudin Revenue by Country/Region (2018-2023) & ($ millions)
    Table 32. Global Hirudin Revenue Market Share by Country/Region (2018-2023)
    Table 33. Americas Hirudin Sales by Country (2018-2023) & (K MT)
    Table 34. Americas Hirudin Sales Market Share by Country (2018-2023)
    Table 35. Americas Hirudin Revenue by Country (2018-2023) & ($ Millions)
    Table 36. Americas Hirudin Revenue Market Share by Country (2018-2023)
    Table 37. Americas Hirudin Sales by Type (2018-2023) & (K MT)
    Table 38. Americas Hirudin Sales by Application (2018-2023) & (K MT)
    Table 39. APAC Hirudin Sales by Region (2018-2023) & (K MT)
    Table 40. APAC Hirudin Sales Market Share by Region (2018-2023)
    Table 41. APAC Hirudin Revenue by Region (2018-2023) & ($ Millions)
    Table 42. APAC Hirudin Revenue Market Share by Region (2018-2023)
    Table 43. APAC Hirudin Sales by Type (2018-2023) & (K MT)
    Table 44. APAC Hirudin Sales by Application (2018-2023) & (K MT)
    Table 45. Europe Hirudin Sales by Country (2018-2023) & (K MT)
    Table 46. Europe Hirudin Sales Market Share by Country (2018-2023)
    Table 47. Europe Hirudin Revenue by Country (2018-2023) & ($ Millions)
    Table 48. Europe Hirudin Revenue Market Share by Country (2018-2023)
    Table 49. Europe Hirudin Sales by Type (2018-2023) & (K MT)
    Table 50. Europe Hirudin Sales by Application (2018-2023) & (K MT)
    Table 51. Middle East & Africa Hirudin Sales by Country (2018-2023) & (K MT)
    Table 52. Middle East & Africa Hirudin Sales Market Share by Country (2018-2023)
    Table 53. Middle East & Africa Hirudin Revenue by Country (2018-2023) & ($ Millions)
    Table 54. Middle East & Africa Hirudin Revenue Market Share by Country (2018-2023)
    Table 55. Middle East & Africa Hirudin Sales by Type (2018-2023) & (K MT)
    Table 56. Middle East & Africa Hirudin Sales by Application (2018-2023) & (K MT)
    Table 57. Key Market Drivers & Growth Opportunities of Hirudin
    Table 58. Key Market Challenges & Risks of Hirudin
    Table 59. Key Industry Trends of Hirudin
    Table 60. Hirudin Raw Material
    Table 61. Key Suppliers of Raw Materials
    Table 62. Hirudin Distributors List
    Table 63. Hirudin Customer List
    Table 64. Global Hirudin Sales Forecast by Region (2024-2029) & (K MT)
    Table 65. Global Hirudin Revenue Forecast by Region (2024-2029) & ($ millions)
    Table 66. Americas Hirudin Sales Forecast by Country (2024-2029) & (K MT)
    Table 67. Americas Hirudin Revenue Forecast by Country (2024-2029) & ($ millions)
    Table 68. APAC Hirudin Sales Forecast by Region (2024-2029) & (K MT)
    Table 69. APAC Hirudin Revenue Forecast by Region (2024-2029) & ($ millions)
    Table 70. Europe Hirudin Sales Forecast by Country (2024-2029) & (K MT)
    Table 71. Europe Hirudin Revenue Forecast by Country (2024-2029) & ($ millions)
    Table 72. Middle East & Africa Hirudin Sales Forecast by Country (2024-2029) & (K MT)
    Table 73. Middle East & Africa Hirudin Revenue Forecast by Country (2024-2029) & ($ millions)
    Table 74. Global Hirudin Sales Forecast by Type (2024-2029) & (K MT)
    Table 75. Global Hirudin Revenue Forecast by Type (2024-2029) & ($ Millions)
    Table 76. Global Hirudin Sales Forecast by Application (2024-2029) & (K MT)
    Table 77. Global Hirudin Revenue Forecast by Application (2024-2029) & ($ Millions)
    Table 78. The Medicines Company Basic Information, Hirudin Manufacturing Base, Sales Area and Its Competitors
    Table 79. The Medicines Company Hirudin Product Portfolios and Specifications
    Table 80. The Medicines Company Hirudin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
    Table 81. The Medicines Company Main Business
    Table 82. The Medicines Company Latest Developments
    Table 83. Keyken Basic Information, Hirudin Manufacturing Base, Sales Area and Its Competitors
    Table 84. Keyken Hirudin Product Portfolios and Specifications
    Table 85. Keyken Hirudin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
    Table 86. Keyken Main Business
    Table 87. Keyken Latest Developments
    Table 88. Minapharm Basic Information, Hirudin Manufacturing Base, Sales Area and Its Competitors
    Table 89. Minapharm Hirudin Product Portfolios and Specifications
    Table 90. Minapharm Hirudin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
    Table 91. Minapharm Main Business
    Table 92. Minapharm Latest Developments
    Table 93. Abbott Basic Information, Hirudin Manufacturing Base, Sales Area and Its Competitors
    Table 94. Abbott Hirudin Product Portfolios and Specifications
    Table 95. Abbott Hirudin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
    Table 96. Abbott Main Business
    Table 97. Abbott Latest Developments
    Table 98. SALUBRIS Basic Information, Hirudin Manufacturing Base, Sales Area and Its Competitors
    Table 99. SALUBRIS Hirudin Product Portfolios and Specifications
    Table 100. SALUBRIS Hirudin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
    Table 101. SALUBRIS Main Business
    Table 102. SALUBRIS Latest Developments
    Table 103. Pfizer, Inc Basic Information, Hirudin Manufacturing Base, Sales Area and Its Competitors
    Table 104. Pfizer, Inc Hirudin Product Portfolios and Specifications
    Table 105. Pfizer, Inc Hirudin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
    Table 106. Pfizer, Inc Main Business
    Table 107. Pfizer, Inc Latest Developments
    Table 108. Teva Pharmaceutical Industries Ltd Basic Information, Hirudin Manufacturing Base, Sales Area and Its Competitors
    Table 109. Teva Pharmaceutical Industries Ltd Hirudin Product Portfolios and Specifications
    Table 110. Teva Pharmaceutical Industries Ltd Hirudin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
    Table 111. Teva Pharmaceutical Industries Ltd Main Business
    Table 112. Teva Pharmaceutical Industries Ltd Latest Developments
    Table 113. DUOPUTAI Basic Information, Hirudin Manufacturing Base, Sales Area and Its Competitors
    Table 114. DUOPUTAI Hirudin Product Portfolios and Specifications
    Table 115. DUOPUTAI Hirudin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
    Table 116. DUOPUTAI Main Business
    Table 117. DUOPUTAI Latest Developments
    Table 118. Pentapharm Basic Information, Hirudin Manufacturing Base, Sales Area and Its Competitors
    Table 119. Pentapharm Hirudin Product Portfolios and Specifications
    Table 120. Pentapharm Hirudin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
    Table 121. Pentapharm Main Business
    Table 122. Pentapharm Latest Developments
List of Figures
    Figure 1. Picture of Hirudin
    Figure 2. Hirudin Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Hirudin Sales Growth Rate 2018-2029 (K MT)
    Figure 7. Global Hirudin Revenue Growth Rate 2018-2029 ($ Millions)
    Figure 8. Hirudin Sales by Region (2018, 2022 & 2029) & ($ Millions)
    Figure 9. Product Picture of Natural Hirudin
    Figure 10. Product Picture of Recombinant Hirudin
    Figure 11. Global Hirudin Sales Market Share by Type in 2022
    Figure 12. Global Hirudin Revenue Market Share by Type (2018-2023)
    Figure 13. Hirudin Consumed in Thrombosis Disease
    Figure 14. Global Hirudin Market: Thrombosis Disease (2018-2023) & (K MT)
    Figure 15. Hirudin Consumed in Tumor Disease
    Figure 16. Global Hirudin Market: Tumor Disease (2018-2023) & (K MT)
    Figure 17. Hirudin Consumed in Others
    Figure 18. Global Hirudin Market: Others (2018-2023) & (K MT)
    Figure 19. Global Hirudin Sales Market Share by Application (2022)
    Figure 20. Global Hirudin Revenue Market Share by Application in 2022
    Figure 21. Hirudin Sales Market by Company in 2022 (K MT)
    Figure 22. Global Hirudin Sales Market Share by Company in 2022
    Figure 23. Hirudin Revenue Market by Company in 2022 ($ Million)
    Figure 24. Global Hirudin Revenue Market Share by Company in 2022
    Figure 25. Global Hirudin Sales Market Share by Geographic Region (2018-2023)
    Figure 26. Global Hirudin Revenue Market Share by Geographic Region in 2022
    Figure 27. Americas Hirudin Sales 2018-2023 (K MT)
    Figure 28. Americas Hirudin Revenue 2018-2023 ($ Millions)
    Figure 29. APAC Hirudin Sales 2018-2023 (K MT)
    Figure 30. APAC Hirudin Revenue 2018-2023 ($ Millions)
    Figure 31. Europe Hirudin Sales 2018-2023 (K MT)
    Figure 32. Europe Hirudin Revenue 2018-2023 ($ Millions)
    Figure 33. Middle East & Africa Hirudin Sales 2018-2023 (K MT)
    Figure 34. Middle East & Africa Hirudin Revenue 2018-2023 ($ Millions)
    Figure 35. Americas Hirudin Sales Market Share by Country in 2022
    Figure 36. Americas Hirudin Revenue Market Share by Country in 2022
    Figure 37. Americas Hirudin Sales Market Share by Type (2018-2023)
    Figure 38. Americas Hirudin Sales Market Share by Application (2018-2023)
    Figure 39. United States Hirudin Revenue Growth 2018-2023 ($ Millions)
    Figure 40. Canada Hirudin Revenue Growth 2018-2023 ($ Millions)
    Figure 41. Mexico Hirudin Revenue Growth 2018-2023 ($ Millions)
    Figure 42. Brazil Hirudin Revenue Growth 2018-2023 ($ Millions)
    Figure 43. APAC Hirudin Sales Market Share by Region in 2022
    Figure 44. APAC Hirudin Revenue Market Share by Regions in 2022
    Figure 45. APAC Hirudin Sales Market Share by Type (2018-2023)
    Figure 46. APAC Hirudin Sales Market Share by Application (2018-2023)
    Figure 47. China Hirudin Revenue Growth 2018-2023 ($ Millions)
    Figure 48. Japan Hirudin Revenue Growth 2018-2023 ($ Millions)
    Figure 49. South Korea Hirudin Revenue Growth 2018-2023 ($ Millions)
    Figure 50. Southeast Asia Hirudin Revenue Growth 2018-2023 ($ Millions)
    Figure 51. India Hirudin Revenue Growth 2018-2023 ($ Millions)
    Figure 52. Australia Hirudin Revenue Growth 2018-2023 ($ Millions)
    Figure 53. China Taiwan Hirudin Revenue Growth 2018-2023 ($ Millions)
    Figure 54. Europe Hirudin Sales Market Share by Country in 2022
    Figure 55. Europe Hirudin Revenue Market Share by Country in 2022
    Figure 56. Europe Hirudin Sales Market Share by Type (2018-2023)
    Figure 57. Europe Hirudin Sales Market Share by Application (2018-2023)
    Figure 58. Germany Hirudin Revenue Growth 2018-2023 ($ Millions)
    Figure 59. France Hirudin Revenue Growth 2018-2023 ($ Millions)
    Figure 60. UK Hirudin Revenue Growth 2018-2023 ($ Millions)
    Figure 61. Italy Hirudin Revenue Growth 2018-2023 ($ Millions)
    Figure 62. Russia Hirudin Revenue Growth 2018-2023 ($ Millions)
    Figure 63. Middle East & Africa Hirudin Sales Market Share by Country in 2022
    Figure 64. Middle East & Africa Hirudin Revenue Market Share by Country in 2022
    Figure 65. Middle East & Africa Hirudin Sales Market Share by Type (2018-2023)
    Figure 66. Middle East & Africa Hirudin Sales Market Share by Application (2018-2023)
    Figure 67. Egypt Hirudin Revenue Growth 2018-2023 ($ Millions)
    Figure 68. South Africa Hirudin Revenue Growth 2018-2023 ($ Millions)
    Figure 69. Israel Hirudin Revenue Growth 2018-2023 ($ Millions)
    Figure 70. Turkey Hirudin Revenue Growth 2018-2023 ($ Millions)
    Figure 71. GCC Country Hirudin Revenue Growth 2018-2023 ($ Millions)
    Figure 72. Manufacturing Cost Structure Analysis of Hirudin in 2022
    Figure 73. Manufacturing Process Analysis of Hirudin
    Figure 74. Industry Chain Structure of Hirudin
    Figure 75. Channels of Distribution
    Figure 76. Global Hirudin Sales Market Forecast by Region (2024-2029)
    Figure 77. Global Hirudin Revenue Market Share Forecast by Region (2024-2029)
    Figure 78. Global Hirudin Sales Market Share Forecast by Type (2024-2029)
    Figure 79. Global Hirudin Revenue Market Share Forecast by Type (2024-2029)
    Figure 80. Global Hirudin Sales Market Share Forecast by Application (2024-2029)
    Figure 81. Global Hirudin Revenue Market Share Forecast by Application (2024-2029)

The Medicines Company
Keyken
Minapharm
Abbott
SALUBRIS
Pfizer, Inc
Teva Pharmaceutical Industries Ltd
DUOPUTAI
Pentapharm

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

• Primary Source
  Players/Suppliers
  Industry Experts
  Distributors/Traders
  Opinion Leaders
  Front-line Staff
  Marketing Executives

  Secondary Source
  Journals and Periodicals
  Government Bodies
  Annual Reports
  Presentations
  Paid Databases
  LPI Internal Repository

• Data Synthesis
  Information Gathering
  Collation of Data
  Estimation of Key Figures
  Analysis of Derived Insights

  Data Validation
  Triangulation with Data Models
  Reference Against Proprietary
  Databases
  Corroboration with Industry Experts

• Qualitative Analysis
  Market drivers
  Market challenges
  Market trends
  Five forces analysis

  Qualitative Analysis
  Market size and forecast
  Market segmentation
  Geographical insights
  Competitive landscape